UBS Maintains a 'Sell' on athenahealth (ATHN); Decent Quarter, But Valuation Too High
Go back to UBS Maintains a 'Sell' on athenahealth (ATHN); Decent Quarter, But Valuation Too High| Athenahealth, Inc. (NYSE: ATHN) | Delayed: 9.59 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $9.59 | 52 Week High | $170.42 | |||
| Open | $9.59 | 52 Week Low | $98.80 | |||
| Day High | $9.59 | P/E | 137.00 | |||
| Day Low | $9.59 | EPS | $0.07 | |||
| Volume | 1,836,124 | |||||
| Health Management Associates Inc. Cl A (NYSE: HMA) | Delayed: 10.54 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $10.54 | 52 Week High | $17.28 | |||
| Open | $2.45 | 52 Week Low | $9.68 | |||
| Day High | $10.54 | P/E | N/A | |||
| Day Low | $10.54 | EPS | $-0.06 | |||
| Volume | 21,463 | |||||
